English (United Kingdom)Русский (Russian Federation)

News and Events

Monday, 28 March 2011 15:20

We strive to exceed what we promise, because we have the expertise, motivation and flexibility to fulfill your requirements.

  • At a reasonable price
  • At agreed timelines
  • With the best quality
  • To your satisfaction

Here are some of the reasons why pharmaceutical outsourcing in Russia and C&EE with Cromos Pharma is a logical choice:

1. Performance: We have the depth and practical experience:

  • Operating in Russia and Eastern Europe – the most compelling pharma markets
  • Large pool of potential study subjects
  • Highly motivated and GCP-trained Investigators
  • High recruitment rates of eligible patients
  • High-quality and reliable clinical research data
  • Low dropout and data query rates (even when compared with Western Europe and the US)
  • Cromos Pharma’s well-established ties within the Russian medical community and direct interactions with the regulatory authorities
  • Full GCP compliance
  • Experience in conducting of multinational trials
  • Cromos Pharma is a member of Russian Association of Clinical Trials Organizations (ACTO) –non-commercial organization of the leading pharma and pharmaceutical outsourcing companies involved in clinical trials in Russia.

2. Reliability: When it comes to delivering results, our goal is not just to meet but to exceed your expectations. We are determined to fulfill all obligations and promises that we give to our customers.

3. Quality: Cromos Pharma guarantees its customers the highest quality of information and services. All research projects are conducted with the highest degree of accuracy to ensure that our client's internal guidelines are respected and met.

4. Flexibility: We try to adjust to ever-changing industry needs. We believe in a personal, tailored approach to each customer.

5. Confidentiality: Strict confidentiality has become the cornerstone of lasting partnerships with many of our clients. Prior to working with any new client, we execute detailed nondisclosure agreements with all parties involved, ensuring the protection of valuable information right from the beginning.

6. Research team: Our recipe for success is our excellent research team that consists of permanently employed physicians with at least 5 years industry-related experience and at least 3 years of research experience. They are citizens of the respective country, fluent in English and have good knowledge of the local medical community and medical standards. They are exceptionally well trained, highly motivated, and have a unique expertise on how to successfully manage local clinical trials. It is our policy not to rotate CRAs between projects.

7. Range of Services: Pharmaceutical outsourcing with Cromos Pharma means a fully integrated approach to early and late phase clinical trials. We offer client-oriented services according to the highest standards of pharmaceutical research. Moreover, with creation of 3C Alliance we can offer full non-outsourced service, starting from regulatory approvals and clinical trial monitoring and continuing with logistical support of importation of study materials, warehousing and distribution.

8. Customer Service: We consider effective communication and reporting to be the cornerstone of successful clinical research and long-lasting professional relationship with our clients. Meetings and teleconferences keep our projects on track. Our standard and custom reports assure clients are advised of all critical project milestones. We track subject enrollment rates, CRF progress and query status - any metric a sponsor needs to keep abreast of the project. We provide 24/7 support to the client.

 
News and messages from CEO,
Dr Vladimir Bogin
05.01.2012

Meet Cromos Pharma's CEO, Dr. Vladimir Bogin at the 30th JP Morgan Healthcare Conference in San Francisco, CA on 9-12 January 2012.

[...]

14.12.2011

Cromos Pharma published a white paper with review of Russian clinical trials market in 2011.

[...]

28.10.2011

Cromos Pharma's CEO, Dr. Vladimir Bogin has participated in the annual Rusnanotech forum in Moscow, Russia on 25-28 October 2011 .

[...]

27.09.2011

Meet us at 17th Annual International Partnering Conference BIO-Europe 2011 in Duesseldorf, Germany on 31 October - 02 November 2011.

[...]

31.08.2011

Moscow office of Cromos Pharma has moved to a new facility.

[...]